MediVet Biologics is an animal health focused biotechnology company based in central Kentucky. MediVet Biologics pioneered a same-day stem cell treatment that allows veterinarians to harvest, isolate and activate millions of the patient’s own stem cells prior to application. In addition to stem cell therapy, MediVet Biologics has a portfolio of cutting edge products that include platelet-rich plasma kits and bio-tissue scaffolds. Recently MediVet Biologics published a randomized double-blind placebo controlled study at Kansas State University utilizing stem cells for the treatment of canine osteoarthritis. In 2015 MediVet Biologics launched K9-ACV, an immunotherapy service for canine cancer.